(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 108.69% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 12.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 186.68%.
Prenetics Global's revenue in 2026 is $92,390,000.On average, 5 Wall Street analysts forecast PRE's revenue for 2026 to be $3,091,575,118, with the lowest PRE revenue forecast at $2,922,733,845, and the highest PRE revenue forecast at $3,294,890,156.
In 2027, PRE is forecast to generate $4,905,696,839 in revenue, with the lowest revenue forecast at $4,368,387,144 and the highest revenue forecast at $5,414,465,463.